7801 - 7825 of 8808 Results
Title
Year
-
RESTRICTEDTitle: Longitudinal intracortical diffusivity changes in de-novo Parkinson's disease: A promising imaging biomarkerJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 68Issue #:Start Page: 22End Page: 25Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.09.031Citation Count: 33
-
OPENTitle: Cholinergic activity and levodopa‐induced dyskinesia: a multitracer molecular imaging studyJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 4Issue #: 9Start Page: 632End Page: 639Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.438Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.438Citation Count: 18
-
OPENTitle: Altered sphingolipid function in Alzheimer's disease; a gene regulatory network approachJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 102Issue #:Start Page: 178End Page: 187Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2021.02.001Best OA location URL: https://doi.org/10.1016/j.neurobiolaging.2021.02.001Citation Count: 15
-
OPENTitle: Astrocytes, via RTP801, contribute to cognitive decline by disrupting GABAergic‐regulated connectivity and driving neuroinflammation in an Alzheimer's disease mouse modelJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 21Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.70051Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.70051Citation Count: 0
-
OPENTitle: Human pericytes degrade diverse α-synuclein aggregatesJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 17Issue #: 11Start Page: e0277658End Page: e0277658Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0277658Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0277658&type=printableCitation Count: 14
-
RESTRICTEDTitle: 123I‐FP‐CIT SPECT [(123) I‐2β‐carbomethoxy‐3β‐(4‐iodophenyl)‐N‐(3‐fluoropropyl) nortropane single photon emission computed tomography] Imaging in a p.A53T α‐synuclein Parkinson's disease cohort versus Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 11Start Page: 1734End Page: 1739Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27451Citation Count: 12
-
RESTRICTEDTitle: Personalized prediction of depression in patients with newly diagnosed Parkinson's disease: A prospective cohort studyJournal Name: Journal of Affective DisordersPublisher: Elsevier BVVol: 268Issue #:Start Page: 118End Page: 126Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jad.2020.02.046Citation Count: 23
-
RESTRICTEDTitle: Serum neurofilament light chain levels reflect cortical neurodegeneration in de novo Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 74Issue #:Start Page: 43End Page: 49Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.04.009Citation Count: 53
-
OPENTitle: Simulations predict differing phase responses to excitation vs. inhibition in theta-resonant pyramidal neuronsJournal Name: Journal of NeurophysiologyPublisher: American Physiological SocietyVol: 130Issue #: 4Start Page: 910End Page: 924Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1152/jn.00160.2023Best OA location URL: https://doi.org/10.1152/jn.00160.2023Citation Count: 1
-
OPENTitle: The ZFHX3 GGC Repeat Expansion Underlying Spinocerebellar Ataxia Type 4 has a Common Ancestral FounderJournal Name: Movement DisordersPublisher: WileyVol: 40Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1002/mds.30077Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.30077Citation Count: 1
-
OPENTitle: Gut Microbial Metabolites and Future Risk of Parkinson's Disease: A Metabolome‐Wide Association StudyJournal Name: Movement DisordersPublisher: WileyVol: 40Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.30054Best OA location URL: https://doi.org/10.1002/mds.30054Citation Count: 3
-
RESTRICTEDTitle: PPMI 2.O New Science/New Cohorts - Transforming PPMI (2490)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 94Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.2490Citation Count: 7
-
RESTRICTEDTitle: Intranasal Delivery of pGDNF DNA Nanoparticles Provides Neuroprotection in the Rat 6-Hydroxydopamine Model of Parkinson’s DiseaseJournal Name: Molecular NeurobiologyPublisher: Springer Science and Business Media LLCVol: 56Issue #: 1Start Page: 688End Page: 701Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s12035-018-1109-6Citation Count: 56
-
OPENTitle: The second generation mixed lineage kinase-3 (MLK3) inhibitor CLFB-1134 protects against neurotoxin-induced nigral dopaminergic neuron lossJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 318Issue #:Start Page: 157End Page: 164Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2019.05.002Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6592621Citation Count: 11
-
OPENTitle: Relationships between neuropsychiatric symptoms, subtypes of astrocyte activities, and brain pathologies in Alzheimer's disease and Parkinson's diseaseJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 21Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/alz.70242Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.70242Citation Count: 0
-
OPENTitle: Genome-wide association study of REM sleep behavior disorder in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-025-01078-wBest OA location URL: https://www.nature.com/articles/s41531-025-01078-w.pdfCitation Count: 0
-
OPENTitle: Nicotinamide-N-methyltransferase controls behavior, neurodegeneration and lifespan by regulating neuronal autophagyJournal Name: PLOS GeneticsPublisher: Public Library of Science (PLoS)Vol: 14Issue #: 9Start Page: e1007561End Page: e1007561Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pgen.1007561Best OA location URL: https://journals.plos.org/plosgenetics/article/file?id=10.1371/journal.pgen.1007561&type=printableCitation Count: 39
-
RESTRICTEDTitle: Targeting the Dopaminergic System in AutoimmunityJournal Name: Journal of Neuroimmune PharmacologyPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page: 57End Page: 73Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11481-019-09834-5Citation Count: 72
-
RESTRICTEDTitle: Selection of DNA aptamers that prevent the fibrillization of α-synuclein protein in cellular and mouse modelsJournal Name: Molecular Therapy - Nucleic AcidsPublisher: Elsevier BVVol: 35Issue #: 3Start Page: 102251End Page: 102251Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.omtn.2024.102251Best OA location URL: https://doi.org/10.1016/j.omtn.2024.102251Citation Count: 3
- Determination of optimal vibration dose to treat Parkinson's disease gait symptoms: A clinical trial2024OPENTitle: Determination of optimal vibration dose to treat Parkinson's disease gait symptoms: A clinical trialJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 10Issue #:Start Page: 100248End Page: 100248Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.prdoa.2024.100248Best OA location URL: https://doi.org/10.1016/j.prdoa.2024.100248Citation Count: 0
-
OPENTitle: Nurr1:RXRα heterodimer activation as monotherapy for Parkinson’s diseaseJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 114Issue #: 15Start Page: 3999End Page: 4004Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1616874114Best OA location URL: https://www.pnas.org/content/pnas/114/15/3999.full.pdfCitation Count: 79
-
OPENTitle: Correlation of Presynaptic and Postsynaptic Proteins with Pathology in Alzheimer’s DiseaseJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 25Issue #: 6Start Page: 3130End Page: 3130Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms25063130Best OA location URL: https://www.mdpi.com/1422-0067/25/6/3130/pdf?version=1709891329Citation Count: 5
-
RESTRICTEDTitle: What matters to people with Parkinson’s disease living in Australia?Journal Name: Journal of Clinical NeurosciencePublisher: Elsevier BVVol: 22Issue #: 2Start Page: 338End Page: 341Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jocn.2014.06.097Citation Count: 10
-
OPENTitle: Effect of augmenting cholinergic function on gait and balanceJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-015-0523-xBest OA location URL: https://bmcneurol.biomedcentral.com/track/pdf/10.1186/s12883-015-0523-xCitation Count: 25
-
RESTRICTEDTitle: Intra-arterial bone marrow mononuclear cells for strokeJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 22Issue #: 2Start Page: 105End Page: 106Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(23)00005-4Citation Count: 1